Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Flavivirus pre-membrane protein M (prM protein) is a structural protein produced by cleavage of the viral polyprotein in the endoplasmic reticulum of infected cells. In immature virions, prM forms heterodimers with the envelope E protein, acting as a chaperone to ensure correct folding and to mask the fusion peptide of E, thereby preventing premature activation of membrane fusion. Upon passage through the secretory pathway, prM is cleaved by the host protease furin, releasing the pr fragment and leaving the M protein, which helps stabilize the mature, fusion-competent structure of the virion. The prM/E interface and its processing are critical for infectivity, and both the prM protein and its remnants are major targets in vaccine development and antibody therapeutics. Disruption or misregulation of prM cleavage can result in the production of non-infectious or fusion-inactive virus particles. The prM protein is also implicated in pathogenic processes such as antibody-dependent enhancement, making its accurate inclusion and targeting essential for safe vaccine strategies.
Block maturation—Interfere with prM-E heterodimer formation or furin-mediated cleavage to prevent infectious virus formation. Prevent fusion—Stabilize prM-E interaction, preventing structural rearrangements necessary for membrane fusion. Induce immune response—Present prM/E epitopes in vaccine formulations for protective immunity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Flavivirus pre-membrane protein M (prM protein, sometimes abbreviated as prM/M or M protein in mature virions).